Articles
Media
All VideosCase Based Roundtable SeriesEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsViewpoints
Publications
Digital EditionSupplements And Featured Publications
Conferences
Conference Listing
More
CME/CE
Resources
SponsoredZEISS Clinical CasesZeiss Cataract InsightsZeiss Cataract DigitalizationEnhancing the Patient JourneyEYLEA 8mg for nAMD and DME TreatmentBetween the Lines

Subscribe

  • Articles
  • Media
  • Publications
  • Conferences
  • CME/CE
  • Resources
  • Subscribe
  • AMD
  • Cataract & Refractive
  • Cornea
  • Gene Therapy
  • Glaucoma
  • Inflammation & Infection
  • Paediatrics
  • Retina
Spotlight -
ZEISS Clinical Cases|
Heidelberg Engineering: Enhancing the Patient Journey
Advertisement

Prof. Stylianos Michalakis

Advertisement

Articles by Prof. Stylianos Michalakis

First-ever retinal gene therapy: Does real-world experience back its use?

First-ever retinal gene therapy: Does real-world experience back its use?

ByDr Maximilian J. Gerhardt,Prof. Stylianos Michalakis,Prof. Günther Rudolph,Dr Claudia Priglinger,Prof. Siegfried Priglinger
August 4th 2022

Recent reports of retinal atrophy have raised concerns on potential long-term safety.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Ophthalmology Times Europe

    1

    Sydnexis SYD-101 receives US FDA Complete Response Letter for paediatric myopia treatment

    2

    AAO 2025: Home OCT provides a granular look at retinal pathologies

    3

    AAO 2025: John Berdahl, MD, on different lenses to consider in pseudoexfoliation

    • Advertise
    • About Us
    • Editorial Info
    • Editorial Board
    • Contact Us
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us